ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2363

Increase in Macrophage Infiltration in Scleroderma Esophageal Mucosa Is Associated with Motility and Mucosal Complications

Tai-Ju Lee1, Ting-Yuan Lan1, Ko-Jen Li2, Song-Chou Hsieh2 and Ping-Huei Tseng3, 1National Taiwan University Hospital Hsinchu Branch, Hsinchu City, Taiwan, 2National Taiwan University Hospital, Taipei, Taiwan, 3National Taiwan University Hospital, Taipei City, Taiwan

Meeting: ACR Convergence 2023

Keywords: Monocytes/macrophages, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2352–2369) Systemic Sclerosis & Related Disorders – Clinical Poster III: Translational Science

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The macrophage activation is elevated in systemic sclerosis (SSc) patients, and is implicated in pathogenesis of tissue inflammation, fibrosis, and the development of skin disease and interstitial lung disease. The gastroesophageal manifestations are common in SSc, with significant motility and mucosal complications. In this study, we aimed to investigate the potential influence of macrophages in SSc esophagus.

Methods: In this single-center observational study, we prospectively enrolled patients with SSc and primary gastroesophageal reflux disease (GERD) patients to the study. The SSc patients fulfilled the 2013 ACR/EULAR Classification Criteria. The primary GERD patients were examined by gastroenterologist and rheumatologist by clinical and serology tests to exclude possible autoimmune diseases and other structural gastrointestinal disorders.

The patients underwent a series of esophageal and gastric examinations including upper gastroendoscopy, high-resolution esophageal manometry, and middle-portion esophageal endoscopic mucosal biopsy. The erosive esophagitis was graded with Los Angeles classification and the diagnosis of motility disorder was classified according to Chicago Classification version 4.0.

The esophageal biopsy specimens were examined using light microscopy with hematoxylin-eosin stain, and immunohistochemical stains with CD117, Desmin, CD3, CD20, and CD68.

The statistical significance was calculated using Fisher’s exact test for binomial parameters and Wilcoxon rank sum exact test for continuous and categorical data.

Results: From September 2021 to March 2023, 22 SSc patients and 6 primary gastroesophageal reflux disease patients completed the study. The median ages and female sex were similar across both groups. The rates of erosive esophagitis (59% vs. 33%, p = 0.4) and the LA gradings (p = 0.6%) were comparable. On immunohistochemical stains, the SSc patients exhibited increased T cell (100% vs. 50%, p = 0.006) and macrophage (68% vs. 0%, p = 0.008) infiltrations.

In SSc patients, the presence of esophageal macrophage infiltration was not associated with age, female sex, GERD and dysphagia symptoms, the proportion of the absent contractility on manometry, the interstitial lung disease, the functional vital capacity, or the diffusion of carbon monoxide. However, the macrophage infiltration is associated with a decreased upper esophageal sphincter relaxation pressure (7.7 vs. 11.7 mmHg, p = 0.007) and numerically higher rates of erosive esophagitis (73% vs. 29%, p = 0.074.)

Conclusion: In this study, we found a higher proportion of T cell and macrophage infiltrations in SSc patients compared with primary GERD individuals, irrespective of the mucosal complications. The macrophage infiltration in SSc patients was associated with decreased esophageal sphincter pressure and numerically higher incidence of erosive esophagitis. The observation supported the pathological role of macrophages in SSc and indicated its significance in developing esophageal mucosal and functional complications.

Supporting image 1

GERD, gastroesophageal reflux disease; SSc, systemic sclerosis

Supporting image 2

IRP: integrated relaxation pressure; LA grade: Los Angeles classification grading; LES, lower esophageal sphincter; UES, upper esophageal sphincter


Disclosures: T. Lee: None; T. Lan: None; K. Li: None; S. Hsieh: None; P. Tseng: None.

To cite this abstract in AMA style:

Lee T, Lan T, Li K, Hsieh S, Tseng P. Increase in Macrophage Infiltration in Scleroderma Esophageal Mucosa Is Associated with Motility and Mucosal Complications [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/increase-in-macrophage-infiltration-in-scleroderma-esophageal-mucosa-is-associated-with-motility-and-mucosal-complications/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increase-in-macrophage-infiltration-in-scleroderma-esophageal-mucosa-is-associated-with-motility-and-mucosal-complications/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology